These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38410184)

  • 41. The Nrf2/SKN-1-dependent glutathione S-transferase π homologue GST-1 inhibits dopamine neuron degeneration in a Caenorhabditis elegans model of manganism.
    Settivari R; VanDuyn N; LeVora J; Nass R
    Neurotoxicology; 2013 Sep; 38():51-60. PubMed ID: 23721876
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Parkin deficiency exacerbate ethanol-induced dopaminergic neurodegeneration by P38 pathway dependent inhibition of autophagy and mitochondrial function.
    Hwang CJ; Kim YE; Son DJ; Park MH; Choi DY; Park PH; Hellström M; Han SB; Oh KW; Park EK; Hong JT
    Redox Biol; 2017 Apr; 11():456-468. PubMed ID: 28086194
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Copper-mediated neurotoxicity and genetic vulnerability in the background of neurodegenerative diseases in C. elegans.
    Weishaupt AK; Ruecker L; Meiners T; Schwerdtle T; Silva Avila D; Aschner M; Bornhorst J
    Toxicol Sci; 2024 Oct; 201(2):254-262. PubMed ID: 39067045
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans.
    Chen KS; Menezes K; Rodgers JB; O'Hara DM; Tran N; Fujisawa K; Ishikura S; Khodaei S; Chau H; Cranston A; Kapadia M; Pawar G; Ping S; Krizus A; Lacoste A; Spangler S; Visanji NP; Marras C; Majbour NK; El-Agnaf OMA; Lozano AM; Culotti J; Suo S; Ryu WS; Kalia SK; Kalia LV
    Mol Neurodegener; 2021 Nov; 16(1):77. PubMed ID: 34772429
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Caloric restriction improves glucose homeostasis, yet increases cardiometabolic risk in caveolin-1-deficient mice.
    Mayurasakorn K; Hasanah N; Homma T; Homma M; Rangel IK; Garza AE; Romero JR; Adler GK; Williams GH; Pojoga LH
    Metabolism; 2018 Jun; 83():92-101. PubMed ID: 29410348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rhes Counteracts Dopamine Neuron Degeneration and Neuroinflammation Depending on Gender and Age.
    Costa G; Pinna A; Porceddu PF; Casu MA; Di Maio A; Napolitano F; Usiello A; Morelli M
    Front Aging Neurosci; 2018; 10():163. PubMed ID: 29904346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease.
    Yao C; El Khoury R; Wang W; Byrd TA; Pehek EA; Thacker C; Zhu X; Smith MA; Wilson-Delfosse AL; Chen SG
    Neurobiol Dis; 2010 Oct; 40(1):73-81. PubMed ID: 20382224
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
    Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
    J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Altered substrate metabolism in neurodegenerative disease: new insights from metabolic imaging.
    Cleland NRW; Al-Juboori SI; Dobrinskikh E; Bruce KD
    J Neuroinflammation; 2021 Oct; 18(1):248. PubMed ID: 34711251
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microsomal prostaglandin E synthase-1 is a critical factor in dopaminergic neurodegeneration in Parkinson's disease.
    Ikeda-Matsuo Y; Miyata H; Mizoguchi T; Ohama E; Naito Y; Uematsu S; Akira S; Sasaki Y; Tanabe M
    Neurobiol Dis; 2019 Apr; 124():81-92. PubMed ID: 30423474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.
    Kim HW; Choi WS; Sorscher N; Park HJ; Tronche F; Palmiter RD; Xia Z
    Neurobiol Aging; 2015 Sep; 36(9):2617-27. PubMed ID: 26070241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Manganese exposure exacerbates progressive motor deficits and neurodegeneration in the MitoPark mouse model of Parkinson's disease: Relevance to gene and environment interactions in metal neurotoxicity.
    Langley MR; Ghaisas S; Ay M; Luo J; Palanisamy BN; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
    Neurotoxicology; 2018 Jan; 64():240-255. PubMed ID: 28595911
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Programmed Death-1 Deficiency Aggravates Motor Dysfunction in MPTP Model of Parkinson's Disease by Inducing Microglial Activation and Neuroinflammation in Mice.
    Cheng YY; Chen BY; Bian GL; Ding YX; Chen LW
    Mol Neurobiol; 2022 Apr; 59(4):2642-2655. PubMed ID: 35142987
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression.
    Liu G; Sgobio C; Gu X; Sun L; Lin X; Yu J; Parisiadou L; Xie C; Sastry N; Ding J; Lohr KM; Miller GW; Mateo Y; Lovinger DM; Cai H
    Hum Mol Genet; 2015 Sep; 24(18):5299-312. PubMed ID: 26123485
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kir6.1/K-ATP channel on astrocytes protects against dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease via promoting mitophagy.
    Hu ZL; Sun T; Lu M; Ding JH; Du RH; Hu G
    Brain Behav Immun; 2019 Oct; 81():509-522. PubMed ID: 31288070
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optical imaging of mitochondrial redox state in rodent model of retinitis pigmentosa.
    Maleki S; Gopalakrishnan S; Ghanian Z; Sepehr R; Schmitt H; Eells J; Ranji M
    J Biomed Opt; 2013 Jan; 18(1):16004. PubMed ID: 23291617
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sorbus alnifolia protects dopaminergic neurodegeneration in Caenorhabditis elegans.
    Cheon SM; Jang I; Lee MH; Kim DK; Jeon H; Cha DS
    Pharm Biol; 2017 Dec; 55(1):481-486. PubMed ID: 27937005
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The antiparkinson drug ropinirole inhibits movement in a Parkinson's disease mouse model with residual dopamine neurons.
    Wang Y; Bouabid S; Darvas M; Zhou FM
    Exp Neurol; 2020 Nov; 333():113427. PubMed ID: 32735872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optical imaging of mitochondrial redox state in rodent models with 3-iodothyronamine.
    Ghanian Z; Maleki S; Reiland H; Bütz DE; Chiellini G; Assadi-Porter FM; Ranji M
    Exp Biol Med (Maywood); 2014 Feb; 239(2):151-8. PubMed ID: 24302559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Therapeutic potential of NADH: in neurodegenerative diseases characterizde by mitochondrial dysfunction].
    Chen Z; Wang H; Wang Q
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Jan; 38(1):57-62. PubMed ID: 38297850
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.